Zeidan, Amer M. http://orcid.org/0000-0001-7017-8160
Giri, Smith
DeVeaux, Michelle
Ballas, Samir K.
Duong, Vu H.
Article History
Received: 31 July 2018
Accepted: 29 October 2018
First Online: 9 November 2018
Compliance with ethical standards
:
: Amer M. Zeidan has received research funding from Celgene, Incyte, Takeda, Pfizer, ADC Therapeutics, Medimmune, Trovagene, AbbVie, and Merck; he has consulted for Agios, AbbVie, Otsuka, Pfizer, Gilead, Celgene, Ariad, Incyte, Takeda, and Novartis; and he has served as a speaker for Takeda. Samir K. Ballas has served on the speakers bureau for Novartis and has received honoraria from Novartis. Smith Giri, Michelle DeVeaux, and Vu H. Duong declare that they have no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.